Incidence of Atrial Fibrillation following Alcohol Septal Ablation for Hypertrophic Cardiomyopathy. Issue 5 (11th March 2016)

• Record Type: Journal Article
• Authors: Moss, Travis J.; Zipse, Matthew M.; Krantz, Mori J.; Sauer, William H.; Salcedo, Ernesto E.; Schuller, Joseph L.
• Is Part Of: Annals of noninvasive electrocardiology. Volume 21:Issue 5(2016:Sep.)
• Page Start: 443
• Page End: 449
• Publication Date: 2016-03-11
• Subjects: alcohol septal ablation -- hypertrophic cardiomyopathy -- atrial fibrillation; Electrocardiography -- Periodicals; Arrhythmia -- Periodicals; 616.1207547
• DOI: 10.1111/anec.12335
• Languages: English
• ISSNs: 1082-720X

Abstract

Abstract : Background: Patients with hypertrophic cardiomyopathy (HCM) are at a fourfold to sixfold higher risk of developing atrial fibrillation (AF) compared to the general population, though incidence rates among patients undergoing alcohol septal ablation (ASA) are not well characterized. The purpose of this study was to evaluate atrial fibrillation incidence following ASA. Methods: We studied 132 consecutive HCM patients without comorbid AF that underwent 154 ASA procedures. The incidence of AF in follow‐up was assessed through chart abstraction including electrocardiography. Survival free of AF was estimated using Kaplan‐Meier methodology. Results: Over a mean follow‐up of 3.6 ± 2.7 years (maximum 11.3 years), 10 (7.6%) patients developed new‐onset AF. Of those who developed AF, both resting and provoked left ventricular outflow tract (LVOT) gradients had improved significantly (difference –79.78 mm Hg, P ≤ 0.005). Severity of mitral regurgitation improved in 7 (70%) patients. Survival free of AF was estimated to be 99.1%, 93.7%, and 91.7% at 1, 3, and 5 years. Conclusions: Despite relieving LVOT obstruction and improving mitral regurgitation severity via ASA, new‐onset AF remained a common complication of hypertrophic cardiomyopathy.